Status: Ongoing, but not recruiting participants
ClinicalTrials.gov Identifier: NCT02424019
Alimera “Paladin”: A phase 4 safety study of IOP Signals in patients treated with Iluvien (Fluocinolone Acetonide Intravitreal Implant) 0.19 MG
Condition: Diabetic Macular Edema (DME)
Study Type: Interventional
Duration: 36 Months
Eligibility:
For additional information on this study, please click here
Back to Clinical Research